Butterfly Network (BFLY) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
4 Aug, 2026Executive summary
Achieved record Q2 2026 revenue of $32.6 million, up 39.5% year-over-year, surpassing guidance, driven by Embedded business growth and strong U.S. sales.
Gross margin rose to 71.4%, a 7.7-point increase year-over-year, with adjusted EBITDA loss improving 78% to $1.4 million.
Net loss narrowed to $12.9 million from $13.8 million year-over-year, with loss per share at $(0.05).
Embedded partnerships, especially with Midjourney, and new regulatory approvals in Brazil and the U.S. VA drove expansion.
Expanded product offerings, AI-driven software platforms, and medical education partnerships, including VCOM.
Financial highlights
U.S. revenue grew 57% year-over-year to $27.6 million, while international revenue declined 14% to $5.0 million, offset by Brazil market entry.
Software and services revenue surged 149.8% to $16.9 million, now 51.8% of total revenue; product revenue was $15.7 million, down 5.4%.
Gross profit hit $23.3 million, gross margin reached 71.4%, and operating expenses rose 19% to $37.0 million.
Adjusted EBITDA loss improved to $1.4 million; net loss per share was $(0.05); adjusted EPS improved to $(0.01).
Cash and equivalents at quarter-end were $124.7 million; cash use was $13.3 million in Q2 and $30.2 million in H1 2026.
Outlook and guidance
Q3 2026 revenue expected at $26–$30 million (30% year-over-year growth at midpoint); adjusted EBITDA loss of $6–$9 million.
Full-year 2026 revenue guidance raised to $119–$123 million (22–26% growth); adjusted EBITDA loss of $19–$23 million.
Guidance includes investments in innovation and growth for both core and Embedded businesses.
Management expects continued revenue growth driven by software and Embedded partnerships.
Existing cash and cash flows from operations expected to fund operations for at least the next 12 months.
Latest events from Butterfly Network
- Directors elected, auditor ratified, and executive compensation approved with no stockholder questions.BFLY
AGM 2026 - Semiconductor ultrasound tech, AI ecosystem, and licensing drive growth and industry expansion.BFLY
46th Annual William Blair Growth Stock Conference - AI-powered ultrasound and embedded tech drive global growth and financial improvement.BFLY
Bank of America Global Healthcare Conference 2026 - Q1 2026 revenue up 25%, gross margin at 68.9%, and adjusted EBITDA loss narrowed to $6.1M.BFLY
Q1 2026 - Proxy covers director elections, auditor ratification, and executive pay, with founder holding voting control.BFLY
Proxy filing - Votes include director elections, auditor ratification, and executive pay approval.BFLY
Proxy filing - AI-powered ultrasound and embedded tech drive growth, with 2026 revenue seen at $117M-$121M.BFLY
TD Cowen 46th Annual Health Care Conference - Record Q4 revenue, margin gains, and positive cash flow set stage for 2026 growth.BFLY
Q4 2025 - AI-driven chip innovation, global expansion, and new partnerships fuel strong growth and revenue.BFLY
44th Annual J.P. Morgan Healthcare Conference